Publications by authors named "Sachdev Thomas"

Claim this Profile
S
Sex disparity in survival outcomes of advanced gastric adenocarcinoma.
Minggui Pan, Meng M Tong, Jack Stover, Tina Huang, Arun Dang, Sachdev Thomas

BJC Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of HER2 amplification or overexpression with overall survival in advanced upper gastrointestinal adenocarcinomas.
Minggui Pan, Arun Dang, Tina Huang, Jack Stover, Meng M Tong, Sachdev Thomas

BJC Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma.
Minggui Pan, Maggie Yuxi Zhou, Chen Jiang, Zheyang Zhang, Nam Q Bui, Sachdev Thomas

Clin Cancer Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN pathogenic variants are associated with poor prognosis in patients with advanced soft tissue sarcoma.
Minggui Pan, Maggie Y Zhou, Chen Jiang, Zheyang Zhang, Nam Bui, Sachdev Thomas

BJC Rep· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit.
Benjamin J Bulen, Nickolay A Khazanov, Daniel H Hovelson, Laura E Lamb, Marc Matrana, Sachdev Thomas

Cancer Res Commun· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Gain-of-Function and Non-Gain-of-Function Mutations Are Associated With Differential Prognosis in Advanced Pancreatic Ductal Adenocarcinoma.
Minggui Pan, Chen Jiang, Zheyang Zhang, Ninah Achacoso, Stacey Alexeeff, Sachdev Thomas

JCO Precis Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex- and Co-Mutation-Dependent Prognosis in Patients with SMARCA4-Mutated Malignancies.
Minggui Pan, Chen Jiang, Zheyang Zhang, Ninah Achacoso, Aleyda V Solorzano-Pinto, Sachdev Thomas

Cancers (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit.
Scott A Tomlins, Nickolay A Khazanov, Benjamin J Bulen, Daniel H Hovelson, Melissa J Shreve, Sachdev Thomas

Commun Med (Lond)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Time to Molecular Testing Results in Patients With Newly Diagnosed, Metastatic Non-Small-Cell Lung Cancer.
Stephanie Ossowski, Elad Neeman, Charles Borden, Douglas Stram, Lucy Giraldo, Sachdev Thomas

JCO Oncol Pract· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Gain-of-Function and Non-Gain-of-Function Mutations Are Differentially Associated With Sidedness-Dependent Prognosis in Metastatic Colorectal Cancer.
Minggui Pan, Chen Jiang, Pam Tse, Ninah Achacoso, Stacey Alexeeff, Sachdev Thomas

J Clin Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 multicentre study of single-agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance).
Cara A Rosenbaum, Sin-Ho Jung, Brandelyn Pitcher, Nancy L Bartlett, Sonali M Smith, Sachdev P Thomas

Br J Haematol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-Institutional, Prospective Clinical Utility Study Evaluating the Impact of the 92-Gene Assay (CancerTYPE ID) on Final Diagnosis and Treatment Planning in Patients With Metastatic Cancer With an Unknown or Unclear Diagnosis.
Sachdev P Thomas, Lauren E Jacobson, Anthony R Victorio, Theresa N Operaña, Brock E Schroeder

JCO Precis Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Goblet cell carcinoid of the appendix - diagnostic challenges and treatment updates: a case report and review of the literature.
Gregory Gilmore, Kristin Jensen, Shreyas Saligram, Thomas P Sachdev, Subramanyeswara R Arekapudi

J Med Case Rep· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance).
Martin J Edelman, Xiaofei Wang, Lydia Hodgson, Richard T Cheney, Maria Q Baggstrom, Sachdev P Thomas, Thomas E Stinchcombe

J Clin Oncol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Enjoy glass of wine before eating:" a randomized trial to test the orexigenic effects of this advice in advanced cancer patients.
Aminah Jatoi, Rui Qin, Daniel Satele, Shaker Dakhil, Pankaj Kumar, Sachdev P Thomas

Support Care Cancer· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung Cancer.
Randy F Sweis, Sachdev Thomas, Bruce Bank, Paul Fishkin, Colin Mooney

Cureus· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance).
Neal E Ready, Herbert H Pang, Lin Gu, Gregory A Otterson, Sachdev P Thomas

J Clin Oncol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2, randomized, open-label study of ramucirumab in combination with first-line pemetrexed and platinum chemotherapy in patients with nonsquamous, advanced/metastatic non-small cell lung cancer.
Robert C Doebele, David Spigel, Mustapha Tehfe, Sachdev Thomas, Martin Reck

Cancer· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321.
Yujie Zhao, Nathan R Foster, Jeffrey P Meyers, Sachdev P Thomas, Donald W Northfelt

J Thorac Oncol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCTG N0821 (Alliance): a phase II first-line study of pemetrexed, carboplatin, and bevacizumab in elderly patients with advanced nonsquamous non-small-cell lung cancer with good performance status.
Grace K Dy, Julian R Molina, Yingwei Qi, Rafat Ansari, Sachdev Thomas

J Thorac Oncol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial.
Nitin Jain, Emily Curran, Neil M Iyengar, Ernesto Diaz-Flores, Rangesh Kunnavakkam, Sachdev P Thomas

Clin Cancer Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the impact of bevacizumab maintenance therapy on overall survival in advanced non-small-cell lung cancer.
George Dranitsaris, Nancy Beegle, Arliene Ravelo, Traci Kalberer, Elaine Yu, Sachdev Thomas

Clin Lung Cancer· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cediranib in patients with malignant mesothelioma: a phase II trial of the University of Chicago Phase II Consortium.
Nicholas P Campbell, Rangesh Kunnavakkam, Natasha Leighl, Mark D Vincent, David R Gandara, Sachdev P Thomas

Lung Cancer· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced hand-foot syndrome: North Central Cancer Treatment Group Study N05C5.
Sherry L Wolf, Rui Qin, Smitha P Menon, Kendrith M Rowland, Sachdev Thomas

J Clin Oncol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboplatin and Paclitaxel in combination with either vorinostat or placebo for first-line therapy of advanced non-small-cell lung cancer.
Suresh S Ramalingam, Michael L Maitland, Paul Frankel, Athanassios E Argiris, Marianna Koczywas, Sachdev Thomas

J Clin Oncol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis